ClinicalTrials.gg
Status unknownNCT06419751Updated May 17, 2024

the Effects of Different Exercise on Vascular Health

An interventional study of Regular exercise and Baduanjin in Mind-body Exercise, Vascular Health and M-health, sponsored by China National Center for Cardiovascular Diseases. Status unknown. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-05-17.

Sponsored by China National Center for Cardiovascular Diseases · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified May 2024), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
216
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

To explore the effect of smart app and wearable-based lifestyle intervention management on vascular health, comparing different exercise with the improvement of vascular arterial stiffness. The accuracy and consistency evaluation of smart wearable devices in screening for vascular health risks were also discussed.

Read the detailed description

This study intends to carry out a randomized controlled trial to dynamically monitor a variety of cardiovascular parameters in people with high risk of vascular health, using wearable devices and artificial intelligence-assisted health management platform, and provide intelligent lifestyle intervention programs with different exercise.By observing the improvement of vascular health in the study population, the management effect of intelligent lifestyle intervention on high-risk groups of vascular health was evaluated. It is expected that through comprehensive lifestyle intervention based on smart wearable devices, early prevention and control of arteriosclerosis can be achieved, the level of hospital health management will be improved, and more physical health and health economic benefits will be obtained.

02

Conditions studied

  • Mind-body Exercise
  • Vascular Health
  • M-health
  • Cardiac Rehabilitation

Keywords

  • m-health
  • mind-body exercise
  • cardiac rehabilitation
  • arterial stiffness
03

In context

Lead sponsor

China National Center for Cardiovascular Diseases is the lead sponsor of 262 studies on the registry; 138 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age: ≥ 18 years old and \< 60 years old;
  2. cfPWV>10m/s;
  3. Those who have 1 intelligent communication device and can use it proficiently (Android mobile phone is preferred);
  4. People who have lived and/or worked relatively steadily in the past 6 months;
  5. Signed informed consent.

Exclusion criteria

Exclusion Criteria:

  1. Moderate to severe obesity (≥30kg/m\^2);
  2. Acute myocardial infarction, acute tachyarrhythmia, pulmonary edema, severe aortic stenosis and other serious circulatory respiratory diseases and acute cardiovascular and cerebrovascular diseases;
  3. severe essential hypertension (systolic blood pressure ≥180mmHg and/or diastolic blood pressure ≥110mmHg) or poorly controlled essential hypertension;
  4. Patients with secondary hypertension, acute hypertension, subacute hypertension and hypertensive encephalopathy;
  5. Significant arrhythmia (atrial fibrillation, etc.);
  6. Patients with atherosclerotic cardiovascular diseases, such as coronary heart disease, severe peripheral atherosclerotic diseases, etc.;
  7. Type 1 diabetes, uncontrolled type 2 diabetes or other diseases affecting carbohydrate metabolism;
  8. Severe stenosis of the carotid and/or femoral arteries (resulting in significant abnormalities in the blood flow spectrum); Those who have anatomical abnormalities of the aorta and major branches and cannot complete PWV detection;
  9. Cancer and other major comorbidities affecting arterial blood pressure;
  10. Those who are unable to exercise due to fractures, joint instability and other physical diseases or diseases affecting the locomotor system;
  11. Those who have involuntary physical movements due to mental illness, epilepsy or other diseases;
  12. Those who have a pacemaker installed;
  13. Pregnant/trying to conceive;
  14. Patients with allergies, limb trauma or skin diseases who cannot cooperate with the completion of ABI and baPWV index examinations;
  15. Those who have undergone or plan to have bariatric surgery in the next 12 months;
  16. Those who have participated in other clinical studies in the past 3 months;
  17. Refusal to sign informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
216 participants (estimated)

Study arms

  • No intervention
    Control

    Study participants were given training on dietary patterns, regular monitoring and follow-up through apps and wearable devices, and no forced exercise measures were performed.

  • Active comparator
    Combined Exercise Group

    Study participants were given training on dietary patterns, regular monitoring and follow-up through apps and wearable devices.Based on the status of the study participants and the results of the cardiopulmonary exercise test, the investigators prescribe moderate-intensity aerobic exercise combined with resistance exercise

    Behavioral: Regular exercise

  • Experimental
    Mind-body Exercise Group

    Study participants were given training on dietary patterns, regular monitoring and follow-up through apps and wearable devices.A standardized Baduanjin exercise program consists of eight postures, each training time is about 30 minutes (including 10 min warm-up, 2 times of Baduanjin, and 10 min of relaxation), 5 days/week, a total of 12 weeks.

    Behavioral: Baduanjin

Interventions

  • BehavioralRegular exercise

    Based on the study participant's status and exercise assessment, the investigators prescribe moderate-intensity aerobic exercise combined with resistance exercise. Before each exercise, preparatory activities (10min), 20-30min moderate-intensity aerobic exercise, finishing activities (10min) at the end, 5 days/week, for 12 weeks, and at the same time, choose non-consecutive 3 days of resistance training in 5 aerobic training sessions to increase resistance training (choose 1\~2 muscle groups each time, 4\~5 movements, repeat each action 8\~12 times, repeat 2\~3 sets)

  • BehavioralBaduanjin

    A professional therapist instructed the participants to learn and train Baduanjin before the intervention, and a standardized Baduanjin exercise program included eight postures, each training time was about 50 minutes (including 10 min of warm-up, 2 times of Baduanjin, and 10 min of relaxation), 5 days/week, a total of 12 weeks

06

What researchers measure

Primary outcomes

  1. Cervical femoral pulse wave velocity(cfPWV)

    The cardio-cerebrovascular and aortic function detector (Campura, France, model: Complior Analyse) was used to measure cfPWV, and the study participants were in a supine position, lying flat on the pillow, with their palms up on their sides of the body, so that their whole body was relaxed and rested for about 3 minutes. PWV can reflect arterial stiffness, and the European Society of Cardiology recommends cfPWV \>10 m/s as the definitive threshold for assessing arterial functional changes in hypertension.We monitored cfPWV at baseline,3,6,9 months of the study.

    Time frame: baseline,3months,6months,9 months

Secondary outcomes

  1. Brachi-ankle pulse wave velocity(baPWV)

    The blood pressure of the limbs is measured with the Omron arteriosclerosis detector, and the pulse conduction velocity (baPWV) and ankle-brachial index (ABI) are calculated to automatically evaluate the degree of arteriosclerosis and blood vessel blockage. Positive criteria for baPWV: ≥1400 cm/s or baPWV% ≥ 19% is arteriosclerosis. Lower extremity vascular occlusion (ABI positive criteria): ≤0.9 for peripheral arterial stenosis and ≤0.5 for possible peripheral arterial occlusion.We monitored baPWV at baseline,3,6,9 months of the study.

    Time frame: baseline,3months,6months,9 months

  2. blood pressure

    Blood pressure indicator: systolic blood pressure and diastolic blood pressure.We monitored blood pressure at baseline,3,6,9 months of the study.

    Time frame: baseline,3months,6months,9 months

  3. body weight

    Using bioelectrical impedance analysis to monitor body weight,weight and height will be combined to report BMI in kg/m\^2.We monitored body composition at baseline,3,6,9 months of the study.

    Time frame: baseline,3months,6months,9 months

  4. Lipid metabolism parameters: TC(mmol/L), TG(mmol/L), HDL-C(mmol/L), LDL-C(mmol/L)

    Lipid metabolism indicators: total cholesterol , triglyceride , high density lipoprotein cholesterol, low density lipoprotein cholesterol.We monitored lipid metabolism parameters at baseline,3,6,9 months of the study.

    Time frame: baseline,3months,6months,9 months

  5. Physical fitness

    The measurement of muscle strength, balance and flexibility is completed by the rehabilitation therapist, mainly including: (1) upper limb muscle strength test (dumbbell arm curl test); (2) Lower limb muscle strength test (chair standing and sitting test); (3) balance ability test; (4) Lower limb flexibility assessment (chair sitting body forward bending test); (5) Upper limb flexibility assessment (two-hand dorsum extension test). Participants were observed for changes at baseline, 3,6,9 months.

    Time frame: baseline,3months,6months,9 months

  6. Vascular Health Index

    The PWV was analyzed by the smart watch through ECG (electrocardiogram) and PPG (photoplethysmography) sensors to evaluate the degree of vascular elasticity, and the vascular health index and evaluation were obtained, and the results were divided into low-risk, medium-risk, and high-risk.

    Time frame: baseline,3months,6months,9 months

  7. Application adherence

    Study participants who received remote lifestyle interventions through the app, completed all exercise training content per week, or clocked in ≥ exercise 3 times were considered to have good compliance; Those who check in \< exercise 3 times a week are considered to have poor compliance.

    Time frame: baseline,3months,6months,9 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06419751
Responsible party
Sponsor
First posted
May 17, 2024
Start date
May 30, 2024 (estimated)
Primary completion
Jun 30, 2025 (estimated)
Completion
Jun 30, 2025 (estimated)
Last update
May 17, 2024

Study contacts

Yifan Wu
Contact
wuyifan1127@126.com
01088398069
Xue Feng
principal investigator · Chinese Academy of Medical Sciences, Fuwai Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion